The Business Models of Editing: How CRISPR Will Reshape Pharma, VC, and Regulation Gene editing isn’t just a scientific advancement—it’s a business model detonation. CRISPR-based therapies like EBT-101, developed by …
CRISPR-based Therapies
The Business Models of Editing: How CRISPR Will Reshape Pharma, VC, and Regulation Gene editing isn’t just a scientific advancement—it’s a business model detonation. CRISPR-based therapies like EBT-101, developed by …